Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2021

Jan 12, 2021

29875_dirs_2021-01-12_83718cf2-76cd-41d1-a1aa-376626a0f6ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-01-08

Reporting Person: Lotvin Alan (EVP and President-CVS Caremark)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-01-08 Common Stock M 10100 $54.19 Acquired 18468.6799 Direct
2021-01-08 Common Stock M 15736 $74.29 Acquired 34204.6799 Direct
2021-01-08 Common Stock S 25836 $75.00 Disposed 8368.6799 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-08 Stock Option $54.19 M 10100 Disposed 2029-04-01 Common Stock (10100) Direct
2021-01-08 Stock Option $74.29 M 15736 Disposed 2021-04-01 Common Stock (15736) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 456.848 Indirect
Common Stock (restricted) 10346 Direct
Stock Unit 28643.2685 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Phantom Stock Credits $1.00 Common Stock (556.6312) 556.6312 Direct
Stock Option $102.26 2022-04-01 Common Stock (21386) 21386 Direct
Stock Option $104.82 2023-04-01 Common Stock (27395) 27395 Direct
Stock Option $78.05 2024-04-03 Common Stock (32911) 32911 Direct
Stock Option $62.21 2025-04-01 Common Stock (22541) 22541 Direct
Stock Option $58.34 2030-04-01 Common Stock (140797) 140797 Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 Trading Plan.

F2: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F3: Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.

F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F5: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F6: Option became exercisable in four equal annual installments beginning on 4/1/2016.

F7: Option became exercisable in four equal annual installments beginning on 4/1/2017.

F8: Option became exercisable in four equal annual installments beginning on 4/3/2018.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F10: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.